270, Novartis Investigational Site — Scottdale, Pennsylvania

270, Novartis Investigational Site is a clinical research site located in Scottdale, Pennsylvania, United States 15683.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

270, Novartis Investigational Site has participated in 1 clinical trials.

Therapeutic areas: Influenza Virus.

Sponsors: Seqirus.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Scottdale

Browse all research sites in Pennsylvania · View every site in Scottdale

• Frontier Clinical Research
• Research Site
• GSK Investigational Site
• Frontier Clinical Research - Scottdale
• Furiex Research Site
• 1275.1.01072 Boehringer Ingelheim Investigational Site
• Adaptive Biotechnologies Investigational Site
• Study Center
• #828
• 1245.25.10159 Boehringer Ingelheim Investigational Site
• Investigational Site Number 8400129
• Influence Study Site

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for 270, Novartis Investigational Site?

270, Novartis Investigational Site has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has 270, Novartis Investigational Site conducted?

270, Novartis Investigational Site has 1 clinical trials on record. Their work covers Influenza Virus.

Is 270, Novartis Investigational Site accredited by Crixeo Clinical Trials?

270, Novartis Investigational Site has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about 270, Novartis Investigational Site?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.